CV Sciences, Inc. (OTCMKTS:CVSI – Get Free Report) saw a significant drop in short interest in the month of February. As of February 13th, there was short interest totaling 6,360 shares, a drop of 50.6% from the January 29th total of 12,867 shares. Based on an average daily volume of 2,403,529 shares, the days-to-cover ratio is presently 0.0 days. Currently, 0.0% of the shares of the company are short sold. Currently, 0.0% of the shares of the company are short sold. Based on an average daily volume of 2,403,529 shares, the days-to-cover ratio is presently 0.0 days.
CV Sciences Stock Performance
Shares of OTCMKTS CVSI traded up $0.02 during midday trading on Friday, hitting $0.09. 2,796,063 shares of the company’s stock were exchanged, compared to its average volume of 1,469,821. CV Sciences has a twelve month low of $0.02 and a twelve month high of $0.10. The stock’s 50 day moving average price is $0.05 and its 200-day moving average price is $0.04. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.21 and a current ratio of 1.07.
CV Sciences Company Profile
CV Sciences, Inc is a developer, manufacturer and marketer of hemp-derived products, with a focus on cannabidiol (CBD) formulations for both consumer and industrial applications. The company’s consumer segment offers a range of dietary supplements, topical creams, personal care items and pet products under its flagship PlusCBD™ Oil brand, while its industrial segment provides hemp-derived ingredients for use in wellness, pharmaceutical and cosmetic formulations.
Headquartered in San Diego, California, CV Sciences operates a manufacturing facility in El Cajon that oversees cultivation partnerships, extraction, refinement and product formulation.
Recommended Stories
- Five stocks we like better than CV Sciences
- The gold chart Wall Street is terrified of…
- This makes me furious
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for CV Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CV Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
